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The antiviral adaptor proteins Cardif and Trif are
processed and inactivated by caspases
M Rebsamen1,3, E Meylan1,3,4, J Curran2 and J Tschopp*,1
The outcome of a viral infection depends on the interplay between the host’s capacity to trigger potent antiviral responses and
viral mechanisms that counteract them. Although Toll-like receptor (TLR)-3, which recognizes virally derived double-stranded
(ds) RNA, transmits downstream antiviral signaling through the TIR adaptor Trif (TICAM-1), viral RNA-sensing RIG-like helicases
(RLHs) use the mitochondrial-bound CARD protein Cardif (IPS-1/MAVS/VISA). The importance of these two antiviral signaling
pathways is reflected by the fact that both adaptors are inhibited through specific cleavage triggered by the hepatitis C virus
serine protease NS3-4A. Here, we show that inactivation can also occur through cellular caspases activated by various
pro-apoptotic signals. Upon caspase-dependent cleavage both adaptors loose their capacity to activate the transcription factors
interferon regulatory factors (IRF) and NF-jB. Importantly, poliovirus infection triggers a caspase-dependent cleavage of Cardif,
suggesting that some viruses may activate caspases not only as a mean to facilitate shedding and replication, but also to impair
antiviral responses.
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During microbial infection, it is crucial for the host to rapidly
mount efficient innate immune responses. Several pathogen
recognition systems exist to ensure such an innate response.
The best-known examples are the transmembrane Toll-like
receptors (TLR), which in most cases recognize extracellular
pathogen-associated molecular patterns. These pathogen-
associated molecular patterns are essential molecules for the
microbes and are diverse in composition, including sugars,
lipids, proteins and nucleic acids.1,2 All TLRs initiate intra-
cytoplasmic signaling events through their Toll-interleukin-1
receptor (TIR) domain by recruiting TIR domain-containing
adaptor molecules through homotypic (TIR–TIR) interactions.
Five TIR adaptors have been described so far in mammals.3
One of them, MyD88, is recruited to all TLRs, with the
exception of TLR3. Upon activation by double-stranded (ds)
RNA, TLR3 triggers downstream signaling through TIR
domain-containing adapter inducing IFN-b (Trif), another
TIR adaptor.4–6
TLR3 serves antiviral functions through the sensing of
virally derived dsRNA species within endosomal compart-
ments. TLR7/8 and TLR9 are other endosome-associated
nucleic acid sensors, which detect single-stranded (ss)RNA
and non-methylated CpG DNA, respectively. All these
TLRs, when detecting foreign nucleic acids within endo-
somes, activate the transcription factors interferon regulatory
factors (IRF), IRF3 and IRF7, which trigger the production
of antiviral type-I interferons (IFN).7 More recently, other,
TLR-independent, antiviral surveillance systems have been
described, which rely on the detection of cytoplasmic RNA
of viral origin by RIG-like helicases. Two of them, RIG-I
and MDA5, have been well characterized.8,9 Although both
helicases use their N-terminal caspase recruitment domains
(CARD) to recruit the mitochondrial-bound CARD adaptor
Cardif (CARD adaptor-inducing interferon-b; also called
IPS-1, MAVS and VISA), they sense different viruses.10–15
In-depth analysis of the corresponding knockout mice revealed
that MDA5 mounts innate responses to picornaviruses,
whereas RIG-I is activated by certain flaviviruses, vesicular
stomatitis virus (VSV), Sendai virus and influenza virus.16,17
The importance of antiviral systems is in parallel with the
number of viruses that target the signaling pathway. In support
of this notion, both Trif and Cardif are specifically cleaved and
inactivated by the hepatitis C virus (HCV) NS3-4A serine
protease.12,18 Although NS3-4A-mediated cleavage induces
the release of Cardif from the mitochondria, thereby impairing
downstream signaling events,19,20 cleavage of Trif is believed
to preclude recruitment and assembly of effector proteins.
Hepatitis A virus (HAV) also cleaves and inactivates Cardif,
further supporting its essential role in antiviral defense.21
The importance of Cardif and Trif in the antiviral response
prompted us to postulate that other viruses might also target
these effectors. In principle, viruses may use their own
proteases (such as HCV and HAV) or, alternatively, activate
cellular proteases, which in turn cleave the cellular proteins.
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As viral infection is frequently associated with cell death, we
reasoned that caspases might represent potential proteases
for Cardif or Trif cleavage. Here, we show that both adaptors
are efficiently cleaved by caspases, leading to their inactiva-
tion. Importantly, caspase activation initiated during infection
with poliovirus causes Cardif cleavage. As poliovirus belongs
to the picornavirus family that is sensed by MDA5, poliovirus
may target Cardif for cleavage as a mean to evade innate
immune responses.
Results
Cardif and Trif are cleaved by caspases. To determine
whether caspases could cleave Cardif, we triggered
apoptosis in a U-2 OS-derived cell line by adding
recombinant Fas ligand (FasL) (Figure 1a). A Cardif
fragment of approximately 50 kDa was generated, which
was smaller in size than the 70 kDa fragment generated by
the HCV NS3-4A serine protease (Figure 1a).12,19,22,23 As
expected, FasL, but not NS3-4A-mediated cleavage, was
caspase-dependent, because incubation with the broad
caspase inhibitor zVAD only blocked the former (Figure 1a).
Stimulation of cells with other apoptosis inducers, such as
staurosporine, or the DNA-damaging agents etoposide,
doxorubicin and camptothecin also resulted in Cardif clea-
vage in a Jurkat T-cell line (Figure 1b), demonstrating that the
triggering of various pro-apoptotic pathways can result in
Cardif processing. Recently, Cardif was shown to interact with
caspase-8, most likely indirectly via Fas-associated death
domain protein (FADD).24 We therefore tested the possibility
that this caspase was responsible for Cardif cleavage by using
a Jurkat T-cell clone that lacks caspase-8.25 However, in this
setting, Cardif cleavage still occurred upon incubation with the
different apoptosis inducers, with the exception of FasL as
expected (caspase-8 being a crucial component of the Fas
signaling pathway) (Figure 1b). This strongly suggests that
caspase-8 does not cleave Cardif directly. Notably, Cardif was
also cleaved upon FasL stimulation in caspase-9-deficient
Jurkat T cells (Supplementary Figure S1). Hence, in an effort
to identify further which caspase(s) was responsible for Cardif
cleavage, we used commercially available inhibitors to
caspase-3, -6, -8, -9 and -10. However, all inhibitors interfered
with Cardif cleavage to some extent (data not shown), most
likely owing to a lack of specificity, as reported recently.26
Furthermore, caspase-3 knockdown Jurkat T cells still
showed Cardif and Trif cleavage upon FasL and etoposide
stimulation, suggesting either that other effector caspases,
such as caspase-6 or -7, cleave these adaptors or that
caspase-3 knockdown was not sufficient to observe dimin-
ished cleavage (Supplementary Figure S2).
We then looked for a putative caspase cleavage site and
found one interesting candidate, D429, in an SQVD motif of
the Cardif gene. This sequence is highly similar to the SQLD
caspase-targeted sequence found in the kinase RIP4, an
activator of NF-kB.27 We mutated D429 into E and over-
expressed wild-type (WT), Cardif C508A (a point mutant that
is resistant to NS3-4A-mediated cleavage)12 and Cardif
D429E mutant in 293T-6 cells (Figure 1c and d). 293T-6
cells, which originate from 293T, were used for their higher
sensitivity to FasL as compared with the parental cells.28 The
D429E mutant construct, but neither WT nor C508A Cardif,
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Figure 1 Cardif is cleaved by caspases. (a) U-2 OS human osteosarcoma-derived cell lines inducibly expressing NS3-4A upon tetracycline (Tet) withdrawal were treated
with 100 ng/ml of Fc:FasL for 6 h with or without zVAD (25 mM). Where indicated NS3-4A was induced by the removal of Tet 18 h before Fc:FasL treatment. Cell extracts were
analyzed by immunoblotting. (b) Jurkat T cells, either wild type (WT) or caspase-8 deficient, were stimulated with the indicated pro-apoptotic stimuli for 6 h in the presence or
absence of zVAD. Cell extracts were analyzed by immunoblotting. (c) HEK293T-6 cells were transfected with the indicated VSV-Cardif constructs. zVAD was added after the
removal of the transfection medium (8 h after transfection). At 18 h after transfection, cells were treated with 100 ng/ml Fc:FasL for 6 h and cell extracts were analyzed by
immunoblot. (d) Structural organization of Cardif. CARD, caspase recruitment domain; TR, Traf3 binding site; TM, transmembrane domain
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was resistant to FasL-induced cleavage (Figure 1c), demon-
strating that Cardif is indeed cleaved by caspases at D429.
When the cleaved fragment was purified from a Coomassie
gel and analyzed by mass spectrometry after tryptic digestion,
a non-tryptic peptide ending at amino acid D429 was
obtained, which further supports the Cardif SQVD motif as
the cleavage site targeted by caspases (data not shown).
Hence, Cardif is cleaved near the C terminus by a caspase
during apoptosis triggered by different stimuli.
Upon HCV infection, the TLR3 adaptor molecule Trif is
cleaved by HCV NS3-4A, which is similar to the Cardif
protein.18 In addition, triggering a Trif-dependent pathway can
result in apoptosis, most likely because Trif interacts with
RIP1, which, through its death domain, recruits FADD that
in turn binds to caspase-8.29–32 Collectively, this knowledge
prompted us to test whether Trif was also subjected to
cleavage by caspases. When overexpressed, Trif potently
induced apoptosis, as inferred by cellular morphology
and PARP cleavage (Figure 2a and data not shown), and
was efficiently cleaved in a caspase-dependent manner
(Figure 2a). When scrutinizing for putative caspase sequen-
ces within the Trif molecule, we found the three aspartate
residues, D281 (VAPD), D289 (GLPD) and D340 (SVED), to
be the most likely caspase targets (Figure 2b). Therefore, we
generated point mutations at the corresponding amino acid
positions. When N terminally VSV-tagged WT, D289E and
D340E were expressed, a cleaved fragment of approximately
34 kDa appeared in the absence of zVAD (Figure 2a). This
cleaved fragment most likely corresponds to amino acids
1–281. In contrast, when the D281E point mutant was
expressed, another cleaved fragment, approximately 1 kDa
larger, appeared. This suggested that another aspartate
residue, localized about 10 amino acids after D281, was also
the target of cleavage by caspases. Indeed, a construct in
which both D281 and D289 were mutated to Glu (Trif DDEE)
was resistant to cleavage. Hence, both D281 and D289 are
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Figure 2 Trif is cleaved by caspases. (a) 293T-6 cells were transfected with the indicated VSV-Trif constructs. Where indicated zVAD was added after the removal of the
transfection medium. At 18 h after transfection, cells were treated with 100 ng/ml of Fc:FasL for 6 h and cell extracts were analyzed by immunoblotting. (b) Structural
organization of TRIF. R, RIP homotypic interaction motif (RHIM); TIR, Toll-interleukin-1 receptor. (c) Jurkat T cells were stimulated with 100 ng/ml of Fc:FasL or etoposide (at
the indicated concentrations) for 6 h in the presence or absence of zVAD. Anti-Trif immunoprecipitates (IP) and cell extracts (XT) were analyzed by immunoblot. *Ig(H),
immunoglobulin heavy chain
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targeted by the activity of caspases. Importantly, the
endogenous Trif molecule was also cleaved in response to
FasL or etoposide stimulation in Jurkat T cells (Figure 2c). In
that case, although Trif cleavage was abrogated in FasL-
stimulated caspase-8-deficient cells, it still occurred upon
etoposide treatment, suggesting that caspase-8 does not
directly cleave Trif. Hence, similar to Cardif, the Trif adaptor is
processed not only by HCV NS3-4A but also by caspases.
Cleavage of Cardif and Trif results in their inacti-
vation. To test the functional consequences of caspase-
mediated cleavage, we generated for each adaptor two
deletion constructs representing the N- and C-terminal
cleavage fragments, that is Cardif 1–429, Cardif 430–540,
Trif 1–281 and Trif 290–712, respectively (Figures 1d
and 2b). When individually expressed in cells with an IFN-b
or NF-kB-dependent promoter, we observed that none of
the constructs activated the reporter gene (Figure 3a).
Regarding Cardif, these results are in agreement with
previous findings that showed that when either the
C-terminal transmembrane or the N-terminal caspase recruit-
ment domains is removed, the activity of the molecule is
abolished.10,12,13,15 The Trif C-terminal construct (290–712)
was the only exception retaining NF-kB activation potential
(Figure 3b), most likely because of an ongoing interaction
with RIP1 that results in NF-kB activation.31 In contrast, the
IRF-responsive ISRE Luciferase reporter gene was not
activated by any of the deletion mutants (Figure 3c),
whereas both Cardif and Trif caspase-resistant point
mutant constructs were as efficient as WT counterparts at
promoting IFN-b, NF-kB and ISRE reporter activations
(Figure 3a–c). Moreover, we noticed no inherent
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Figure 3 Cardif- and Trif-mediated IRF and NF-kB activation are compromised by caspase cleavage. 293T cells were transfected with (a) an IFN-b, (b) an NF-kB or (c)
an IRF-responsive (ISRE) reporter plasmid together with an empty plasmid or the indicated Cardif (left) or Trif (right) constructs (at two different doses in panels b and c) and
analyzed for luciferase activity. Data are the mean values from one experiment representative of three independent experiments, each performed in triplicates. Error bars
represent the SD of triplicates of the experiment presented
Regulation of Cardif and Trif by caspases
M Rebsamen et al
1807
Cell Death and Differentiation
differences between Cardif D429E and WT constructs
at promoting antiviral responses, as both molecules
showed comparable antiviral activities when introduced into
Cardif knockdown cells (Supplementary Figure S3).
Interestingly, upon TLR3 triggering, Trif cleavage occurred
concomitantly to diminished NF-kB and IRF3 activations
(Supplementary Figure S4), suggesting that caspase-
mediated cleavage might serve to dampen or limit innate
responses over time.
We next evaluated the endogenous levels of proteins
regulated by Cardif and Trif activities. As the expression of
both RIG-I and MDA5 is induced during antiviral responses
through autocrine and paracrine IFN signaling,9,33 we
monitored Cardif- and Trif-mediated antiviral activities by
analyzing the expressions of the two helicases. Both RIG-I
and MDA5 protein levels were induced by WT and point
mutant Cardif and Trif constructs, whereas no expression
could be detected upon transfection of the deletion mutants
or an empty vector (Figure 4a). Furthermore, when monitored
by ELISA, no or only marginal production of RANTES
was detected upon expression of any of the four deletion
constructs in marked contrast to WT and point mutant forms of
Cardif and Trif (Figure 4b). Altogether, these results indicate
that the promotion of antiviral responses is largely compro-
mised when Cardif and Trif are cleaved by caspases, with the
C-terminal Trif cleavage product retaining NF-kB activation
potential.
Poliovirus infection results in caspase-dependent Cardif
cleavage. Next, we tested whether the cleavage of Cardif by
caspases may be relevant in the context of a viral infection.
As picornaviruses such as encephalomyocarditis virus
are recognized by MDA5,16,17 and, more recently, the polio
picornavirus was reported to cleave MDA5 in a caspase-
dependent manner,34 we sought to determine whether
poliovirus also uses caspases to cleave Cardif. In HeLa
cells, Cardif cleavage became apparent 8 h after poliovirus
infection (Figure 5). Although HAV, another picornavirus
family member, was recently reported to directly cleave
Cardif through its 3ABC protease, it is unlikely that poliovirus
proteases cleave Cardif. Indeed, in poliovirus-infected cells,
cleavage of Cardif was completely blocked by zVAD
(Figure 5), suggesting that poliovirus-induced caspase
activation is responsible for Cardif cleavage.
Discussion
During recent years, many efforts have been made toward
elucidating the pathways implicated in the host defense
against viruses. Crucial molecules were discovered, and
novel pathways were identified and characterized. RIG-like
helicases and TLR3 signaling offer a remarkable example of
such newly described pathways, conferring to the host a
potent antiviral immunity. By interfering with type-I IFN
activities mediated by TLR3 and RIG-like helicases, viruses
gain survival advantages. This strategy is indeed used by
many viruses, including paramyxoviruses whose V protein
directly binds MDA5.8 Cardif is cleaved by viral proteases
present in HAV and HCV.12,21 In this report, we unravel one
additional strategy, which can be used by viruses to dampen
the activity of these two pathways. We found that both the
adaptor molecules Cardif and Trif undergo caspase-depen-
dent cleavage and inactivation during apoptosis.
Although at present it is still unclear which caspase(s) is
responsible for their cleavage, it is unlikely to be caspase-9 or
-8, although the latter has been reported to be indirectly
recruited to both Cardif and Trif, probably through
FADD.24,30,32 Indeed, our data show that Cardif and Trif are
cleaved by several pro-apoptotic stimuli in caspase-8 (and
caspase-9)-deficient cells, and also in caspase-3 knockdown
cells. Interestingly, different caspases might serve distinct
functions in antiviral responses. For example, caspase-8 was
shown to be essential for Cardif-induced NF-kB activation,24
whereas the caspase-8 adaptor FADD mediates an antiviral
response against VSV.35 Here, we demonstrate that other
(non-caspase-8) activities antagonize Cardif and Trif func-
tions. These apparently opposing roles might be reconciled
when considering the duration of an antiviral response.
Indeed, in a first step (the innate defense step), TLR3 and
RIG-I, sensing the presence of viruses, recruit caspase-8 via
Cardif and Trif to promote inflammatory and antiviral reactions
through NF-kB and IRF activation. In a later step, the virus
counter-attacks by activating additional caspases that in turn
inactivate the two antiviral pathways through cleavage of
Cardif and Trif. In some cases such as poliovirus, the caspase
activity might be high enough to trigger apoptosis. A second
model is that caspase cleavage of Trif and Cardif represents a
host mechanism to regulate the extent and/or duration of
antiviral responses. This hypothesis is supported by the
observation of Trif cleavage upon TLR3 triggering by poly(I:C)
(Supplementary Figure S4). Notably, the Trif C-terminal
cleavage fragment still retains some NF-kB activation
potential, suggesting that it might form a cytoplasmic complex
with RIP1, allowing NF-kB responses to persist during cell
death. In contrast, Cardif activities are completely blocked by
caspase-mediated cleavage, which could constitute a general
mechanism dampening inflammatory reactions during cell
death (third hypothesis).
Although many viruses actively inhibit apoptosis, there are
also others that activate it.36 Some viruses may induce
apoptosis as a mean for dissemination, and therefore,
apoptosis may be an important step in the viral life cycle.37,38
It is also now recognized that some viruses directly use
components of the apoptotic pathway to facilitate their
replication.38 The nonstructural protein from the B19 parvo-
virus induces apoptosis in various cell lines. Infection by
Sindbis virus results in apoptosis that can be blocked by the
expression of Bcl-2. Interestingly, inhibition of apoptosis by
Bcl-2 shifts the viral infection from lytic to persistent. Other
viruses, including influenza virus, Dengue virus, various
herpesviruses and HIV, have also been reported to induce
apoptosis as a result of cellular infections.37 Poliovirus,
therefore, is not unique with regard to its ability to induce
apoptosis. Poliovirus-induced apoptosis may, therefore, have
an important function in the viral life cycle through limiting the
host immune responses to the virus and by facilitating viral
persistence.
Cleavage of Trif and Cardif appears to be a viral strategy
that has been adopted by several viruses. The HCV protease
NS3-4A cleaves Cardif after amino acids 508 (Figure 6), only
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a few amino acids before the mitochondrial membrane
anchor site. In contrast, HAV protease 3ABC cleaves Cardif
after amino acid Q427, next to the caspase cleavage
site (D429). Although all these sites are different, their
cleavage results in the complete inactivation of Cardif. The
molecular rationale for this is currently not well understood. As
the known Traf3 binding site (amino acids 143–147)39 is not
affected by the processing of Cardif, it is more likely that
successful Traf3-mediated signaling requires proximity of the
mitochondria, which is impaired upon cleavage in these
cases.
As a few viruses can persist in vivo and cause irreversible
damage to the host, a better understanding of viral evasion
strategies is required for a possible development of antiviral
drugs with high selectivity. One of these viruses, HCV,
efficiently cleaves both Cardif and Trif adaptors through its
serine protease NS3-4A. Interestingly, NS3-4A inhibitors are
currently under development, and initial trials in patients show
very promising results.40 Another example of a major human
health concern is poliovirus, whose infection can be devastat-
ing in humans. As MDA5 recognizes encephalomyocarditis
virus picornavirus within infected cells,16,17 it may also detect
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poliovirus, another picornavirus family member. MDA5 is
cleaved by caspases during apoptosis,41 and during polio-
virus infection, it is subjected to similar caspase-dependent,
proteolytic events.34 Our data show that the MDA5 adaptor
protein, Cardif, is also targeted by caspases in poliovirus-
infected cells. As cleavage of Cardif resulted in the loss of
antiviral activity, it is conceivable that certain viruses (such as
poliovirus) evade innate immune responses through indirect
(cellular protease-mediated) cleavage of crucial host
molecules, thereby enhancing their replication within infected
cells. On the other hand, caspase inhibition by zVAD
treatment did not result in increased type-I IFN induction
upon poliovirus infection, and the viral yields remained
unchanged, when compared with non-treated cells.34 Hence,
future studies should clarify whether caspase-mediated
cleavage of Cardif and Trif is a viral strategy to counteract
host responses, a host strategy to regulate innate immune
responses or a host strategy to limit inflammatory gene
induction during apoptosis.
Materials and Methods
Expression vectors. WT and C508A Cardif constructs, WT Trif and
Luciferase reporter constructs were described.12,31 Cardif (encoding amino acids
1–429 and 430–540) and Trif (encoding amino acids 1–281 and 290–712) deletion
constructs, and Cardif (D429E) and Trif (D281E, D289E, D340E and D281, 289E
(DDEE)) point mutant constructs were amplified by standard and double PCR,
respectively, with Pwo Superyield polymerase (Roche), and cloned into a derivative
of pCR3 (Invitrogen), in frame with a N-terminal VSV or Flag tag. The fidelity of the
PCR amplifications was confirmed by sequencing.
Cell culture conditions. The human embryonic kidney (HEK) 293T, 293T-6
(a cell clone that originates from 293T, which has been selected for its high
sensitivity to FasL)28 and HeLa cells were grown in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% heat-inactivated FCS. The Jurkat
T-cell line, a caspase-8-deficient Jurkat clone (kindly provided by J Blenis, Harvard
Medical School, Boston, MA, USA) and a caspase-9-deficient Jurkat clone,
reconstituted or not with caspase-9 (both kindly provided by I Schmitz, University of
Du¨sseldorf, Germany) were grown in RPMI (Invitrogen) supplemented with 10%
heat-inactivated FCS. U-2 OS human osteosarcoma-derived cell lines that inducibly
express NS3-4A upon tetracycline withdrawal have been described.42
Transfections, immunoprecipitations and immunoblots. These
assays were performed as previously described.31
Reagents. Fc:FasL28 was used at 100 ng/ml unless indicated. zVAD (Alexis)
was used at 25mM. Staurosporine and etoposide (both from Alexis) were used at
250 ng/ml and 50mM, respectively, doxorubicin (Sigma) at 20mg/ml and
camptothecin (Apotech) at 100mM. Antibodies to caspase-8 (804-242), NS3
(1B6), Trif (AL227) Cardif (AT107), MDA5 (AT113) and RIG-I (Alme-1) were from
Alexis. Anti-VSV (P5D4) was from Sigma. Anti-PARP (9542), anti-IkB (9242), anti-
phospho-IkB (9246) and anti-phospho-IRF3 (4947) were from Cell Signaling. Anti-
IRF3 (sc-9082) was from Santa Cruz Technology. For immunoprecipitations,
antibodies to Trif (4596) were from Cell Signaling. The human RANTES ELISA kit
was from R&D Systems.
Luciferase reporter assays. These assays were performed as previously
described.31
Viral infections. HeLa cells were infected for the indicated time points
with poliovirus (strain Mahoney) at a multiplicity of infection of 5. After the indicated
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Figure 5 Poliovirus infection results in caspase-dependent Cardif cleavage.
HeLa cells were infected for the indicated time periods with poliovirus at a multiplicity
of infection of 5. zVAD was added for the same time periods when indicated. Cells
were harvested, lysed in RIPA buffer and analyzed for the cleavage of Cardif by
immunoblotting. *Nonspecific bands
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Figure 6 Model of Cardif and Trif interference by caspases and viral proteases. Both Trif and Cardif are cleaved by caspases and HCV NS3-4A. Moreover, Cardif is also
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time periods, the cells were harvested, lysed in RIPA buffer and analyzed by
immunoblot.
For generation of cells stably expressing an shRNA-targeting Cardif, pLKO.1
vectors (Open Biosystems) were used, either empty (control) or containing the
hairpin (CAAGTTGCCAACTAGCTCAAA). Cardif constructs (both WT and D429E
point mutant) were rendered resistant to knockdown by a double PCR introducing
three silent mutations (underlined nucleotides) in the RNAi sequence (CAAATT
ACCGACTAGCTCAAA). shRNAs to caspase-3 in pLKO.1 vectors were CCGA
AAGGTGGCAACAGAATT (shCasp3.1) and CTAAAGGTGGTGAGGCAATAA
(shCasp3.2).
Lentiviruses were produced using second-generation packaging plasmids
pMD2-VSVG and pCMV-R8.91.43 293T cells were co-transfected with packaging
plasmids and the shRNA-encoding plasmids. Cells were washed 18 h after
transfection. Virus-containing supernatants were collected 24 h after washing,
filtered and used for infection. Jurkat or 293T cells were harvested and resuspended
in virus-containing supernatant. After 36 (Jurkat) or 48 h (293T), cells were washed
and put under puromycin selection (Jurkat: 5 mg/ml; 293T: 2.5mg/ml) for at least
5 days. Five different shRNAs were tested for each target protein. The expression
level of the target protein was assessed by immunoblot, and the most efficiently
silenced cells were selected for further experiments.
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